Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial

Study limitation reported by the research below: “The impact flag 'practice changing' is applied because this is one of the first RCTs directly comparing analogue vs. human basal insulin in LMIC settings, and the null result has direct policy implications for insulin procurement. However, the single-region generalizability is limited.”